|
21 |
Pro-fibrotic effects of CCL18 on human lung fibroblasts are mediated via CCR6
Höhne, Kerstin. - Augsburg : Universität Augsburg, 2024
|
|
|
|
22 |
The WERA cancer center matrix: strategic management of patient access to precision oncology in a large and mostly rural area of Germany
Krebs, Markus. - Augsburg : Universität Augsburg, 2024
|
|
|
|
23 |
Unraveling the role of local ablative therapies for patients with metastatic soft tissue sarcoma – a retrospective multicenter study of the Bavarian university hospitals
Burkhard-Meier, Anton. - Augsburg : Universität Augsburg, 2024
|
|
|
24 |
Concept and feasibility of the Augsburg Longitudinal Plasma Study (ALPS) – a prospective trial for comprehensive liquid biopsy-based longitudinal monitoring of solid cancer patients
Enthalten in Journal of laboratory medicine Bd. 48, 2024, Nr. 3: 107-119. 13 S.
|
|
|
|
25 |
Disclosing tumor biology by means of molecular imaging in a patient with malignant melanoma and chronic lymphocytic leukemia
Enthalten in European journal of nuclear medicine and molecular imaging 15.7.2024: 1-2
|
|
|
|
26 |
An intrapatient dosimetry comparison of 177 Lu-rhPSMA-10.1 and 177 Lu-PSMA-I&T in patients with metastatic castration-resistant prostate cancer
Rinscheid, Andreas. - Augsburg : Universität Augsburg, 2023
|
|
|
|
27 |
Granulomatous dermatitis: a rare pitfall in lymphoma staging with [18F]FDG-PET/CT
Enke, Johanna. - Augsburg : Universität Augsburg, 2023
|
|
|
|
28 |
No association of malignant B‐cell non‐Hodgkin lymphomas with ipsilateral SARS‐CoV‐2 vaccination
Claaß, Luise Victoria. - Augsburg : Universität Augsburg, 2023
|
|
|
|
29 |
P703 Assessment of genetic tumor profiles and clonal evolution by liquid biopsy: the Augsburg Longitudinal Plasma Study (ALPS) [Abstract]
Sommer, Sebastian. - Augsburg : Universität Augsburg, 2023
|
|
|
|
30 |
SSTR antagonists as theranostic option in small cell lung cancer
Liebich, Alessandro. - Augsburg : Universität Augsburg, 2023
|
|
Administration
